These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8487257)

  • 21. Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats.
    Gobbi M; Crespi D; Foddi MC; Fracasso C; Mancini L; Parotti L; Mennini T
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):22-8. PubMed ID: 9228186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain.
    Nagai F; Nonaka R; Satoh Hisashi Kamimura K
    Eur J Pharmacol; 2007 Mar; 559(2-3):132-7. PubMed ID: 17223101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and activity of a new class of dual acting norepinephrine and serotonin reuptake inhibitors: 3-(1H-indol-1-yl)-3-arylpropan-1-amines.
    Mahaney PE; Vu AT; McComas CC; Zhang P; Nogle LM; Watts WL; Sarkahian A; Leventhal L; Sullivan NR; Uveges AJ; Trybulski EJ
    Bioorg Med Chem; 2006 Dec; 14(24):8455-66. PubMed ID: 16973367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a receptor-interaction model for serotonin 5-HT2 receptor antagonists. Predicting selectivity with respect to dopamine D2 receptors.
    Andersen K; Liljefors T; Gundertofte K; Perregaard J; Bøgesø KP
    J Med Chem; 1994 Apr; 37(7):950-62. PubMed ID: 8151622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM; Monge A; Del Río J; Lasheras B
    Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further SAR studies of piperidine-based analogues of cocaine. 2. Potent dopamine and serotonin reuptake inhibitors.
    Tamiz AP; Zhang J; Flippen-Anderson JL; Zhang M; Johnson KM; Deschaux O; Tella S; Kozikowski AP
    J Med Chem; 2000 Mar; 43(6):1215-22. PubMed ID: 10737754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "In vitro" effect of some 5-hydroxy-indolalkylamine derivatives on monoamine uptake system.
    Morón JA; Perez V; Fernández-Alvarez E; Marco JL; Unzeta M
    J Neural Transm Suppl; 1998; 52():343-9. PubMed ID: 9564637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex.
    Bymaster FP; Zhang W; Carter PA; Shaw J; Chernet E; Phebus L; Wong DT; Perry KW
    Psychopharmacology (Berl); 2002 Apr; 160(4):353-61. PubMed ID: 11919662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of new 4-butyl-arylpiperazine-3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives and evaluation for their 5-HT
    Wróbel MZ; Chodkowski A; Marciniak M; Dawidowski M; Maksymiuk A; Siwek A; Nowak G; Turło J
    Bioorg Chem; 2020 Apr; 97():103662. PubMed ID: 32086055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dopamine, serotonin and norepinephrine releasing activities of a series of methcathinone analogs in male rat brain synaptosomes.
    Blough BE; Decker AM; Landavazo A; Namjoshi OA; Partilla JS; Baumann MH; Rothman RB
    Psychopharmacology (Berl); 2019 Mar; 236(3):915-924. PubMed ID: 30341459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.
    Mahaney PE; Kim CY; Coghlan RD; Cohn ST; Heffernan GD; Huselton CA; Terefenko EA; Vu AT; Zhang P; Burroughs KD; Cosmi SA; Bray JA; Johnston GH; Deecher DC; Trybulski EJ
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5807-10. PubMed ID: 19713106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Examination of the D2/5-HT2 affinity ratios of resolved 5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indoles: an enantioselective approach toward the design of potential atypical antipsychotics.
    Mewshaw RE; Abreu ME; Silverman LS; Mathew RM; Tiffany CW; Bailey MA; Karbon EW; Ferkany JW; Kaiser C
    J Med Chem; 1993 Oct; 36(21):3073-6. PubMed ID: 7901415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonergic activity of HP 184: does spontaneous release have a role?
    Smith CP; Woods-Kettelberger AT; Corbett R; Chesson SM; Bores GM; Petko WW; Roehr JE; Kongsamut S
    Neurochem Res; 1996 May; 21(5):575-83. PubMed ID: 8726966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bridged gamma-carbolines and derivatives possessing selective and combined affinity for 5-HT2 and D2 receptors.
    Mewshaw RE; Silverman LS; Mathew RM; Kaiser C; Sherrill RG; Cheng M; Tiffany CW; Karbon EW; Bailey MA; Borosky SA
    J Med Chem; 1993 May; 36(10):1488-95. PubMed ID: 8496917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
    Sánchez C; Hyttel J
    Eur J Pharmacol; 1994 Nov; 264(3):241-7. PubMed ID: 7698161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents.
    Norman MH; Rigdon GC; Navas F; Cooper BR
    J Med Chem; 1994 Aug; 37(16):2552-63. PubMed ID: 7914539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and structure-affinity relationship investigations of 5-heteroaryl-substituted analogues of the antipsychotic sertindole. A new class of highly selective alpha(1) adrenoceptor antagonists.
    Balle T; Perregaard J; Ramirez MT; Larsen AK; Søby KK; Liljefors T; Andersen K
    J Med Chem; 2003 Jan; 46(2):265-83. PubMed ID: 12519065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinity.
    Hatzenbuhler NT; Evrard DA; Harrison BL; Huryn D; Inghrim J; Kraml C; Mattes JF; Mewshaw RE; Zhou D; Hornby G; Lin Q; Smith DL; Sullivan KM; Schechter LE; Beyer CE; Andree TH
    J Med Chem; 2006 Jul; 49(15):4785-9. PubMed ID: 16854086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3-(4-Piperidinyl)- and 3-(8-aza-bicyclo[3.2.1]oct-3-yl)-2-phenyl-1H-indoles as bioavailable h5-HT2A antagonists.
    Crawforth J; Goodacre S; Maxey R; Bourrain S; Patel S; Marwood R; O'Connor D; Herbert R; Hutson P; Rowley M
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2701-3. PubMed ID: 11133072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
    Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
    J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.